Docs Who Lift Oral GLP-1 (Wegovy) Is Here: Dosing, Switching, and What to Expect
10 snips
Jan 20, 2026 They unpack the launch of oral Wegovy and why absorption, SNAC formulation, and dosing rules make it more than a simple pill swap. They cover how to convert injectable doses to oral equivalents and practical barriers like fasting, water volume, and thyroid timing. They discuss switching strategies from tirzepatide, cost and access issues, and variability in weight regain after stopping therapy.
AI Snips
Chapters
Transcript
Episode notes
Oral Wegovy Is Not Just A Pill Version
- Oral semaglutide (Wegovy) uses an SNAC formulation and requires ~10x the dose of injectable semaglutide to reach similar blood levels.
- Oral formulations are not equivalent to a simple pill swap for the shot because absorption and formulation matter.
Individualize Dosing When Switching To Oral
- If switching from injectable 2.4 mg Wegovy, consider jumping to the 25 mg oral dose but individualize based on tolerance.
- Ask patients if they prefer aggressive conversion or a conservative trial due to potential GI intolerance.
Start Low And Titrate With Cost In Mind
- Start oral Wegovy at 1.5 mg for GLP-1–naive patients and titrate upward based on response and tolerance.
- Consider cost and make lower starter doses affordable to improve uptake and adherence.